GL1X · GenesisL1 explorer

Research workbench

Discovery of XL335, a highly potent, selective and orally- active agonist of the farnesoid X receptor (fxr)

Analyse Discovery of XL335, a highly potent, selective and orally- active agonist of… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3FLI
Type
protein
Length
221 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bile acid receptor
UniProt
Q96RI1
Ligands
33Y
Pockets
2 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 75% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABile acid receptorprotein22175% helix, 0% strandQ96RI1

Ligands and binding sites

  • 33Y · 1-methylethyl 3-[(3,4-difluorophenyl)carbonyl]-1,1-dimethyl-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13090.850.943633Y
2930.340.7414empty

Compared structures

  • 3FLI · Discovery of XL335, a Highly Potent, Selective and Orally-Active Agonist of the Farnesoid… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q96RI1 · AlphaFold monomer V2.0 prediction for bile acid receptor (Q96RI1) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.